Inaqovi 35 mg/100 mg film-coated tablets clinical trials

A phase II, multicentre, open label clinical trial evaluating the efficacy and safety of oral decitabine plus ivosidenib in adult patients with newly diagnosed acute myeloid leukemia older than 60 years old and/or who are ineligible for standard induction chemotherapy

This study is for older adults, or those unable to have standard chemotherapy, with newly diagnosed acute myeloid leukaemia. It tests two new medicines, Tibsovo and Inaqovi, taken as tablets, to see if they are safe and effective at treating the cancer.